SPONSOR
Xijing Hospital
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Nausea and VomitingTreatment-naive Prostate CancerSuspected Prostate CancerMolecular ImagingIschemic Stroke
Xijing Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Nausea and Vomiting, Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xijing Hospital
How many clinical trials has Xijing Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Xijing Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Nausea and Vomiting, Treatment-naive Prostate Cancer, Suspected Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xijing Hospital research focus on?
Xijing Hospital clinical trials span Nausea and Vomiting, Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging, Ischemic Stroke. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Xijing Hospital clinical trial?
To participate in a Xijing Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xijing Hospital trials with current recruitment status updated daily.
Clinical Trials by Xijing Hospital
NCT05690802
Recruiting
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Nausea and Vomiting
NCT07531329
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Treatment-naive Prostate Cancer
NCT05032053
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Ischemic Stroke
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology